Business / Finance

RSS

Advaxis CEO issues statement to shareholders regarding recent common stock transition

Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:

5 Mar 2011

BATSK advances 0.3% stock this week in the U.S.

BATS Global Markets, a global stock market operator, reports the BATS 1000 Index advanced 0.3% for the week ending March 4 in the U.S. The S&P 500 Index was up 0.1% for the same period.

5 Mar 2011

MedQuist extends exchange offer for all outstanding shares of common stock

MedQuist Holdings Inc., a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, today announced that it has extended the expiration date for its exchange offer for all issued and outstanding shares of MedQuist Inc. common stock until 5:00 p.m., New York City time, on Friday, March 11, 2011, unless further extended or earlier terminated.

5 Mar 2011

Agenus receives letter from Listing Qualifications Staff of The NASDAQ Stock Market

Agenus Inc. announced today that the company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC on March 3, 2011 indicating that the company is not in compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Requirement") because the bid price for the company's common stock has closed below the minimum $1.00 per share requirement for 30 consecutive business days.

5 Mar 2011

Shares of Bacterin's common stock receive approval for listing on NYSE Amex

Bacterin International Holdings, Inc., a creator and developer of revolutionary bone graft material and anti-infective coatings for medical applications, today announced that its common stock has been approved for listing on the NYSE Amex and has chosen Knight Capital Group as its designated market maker.

5 Mar 2011

Pending merger transaction between Grifols, Talecris has been extended

Grifols S.A. and Talecris Biotherapeutics Holdings Corp. today announced that the outside date under their merger agreement for closing their pending merger transaction has been extended to June 30, 2011 (from March 6, 2011).

5 Mar 2011

Biosante to purchase $25.1 million shares of common stock in registered direct offering

BioSante Pharmaceuticals, Inc. today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering.

5 Mar 2011

Skilled Healthcare Group to transfer operations of five indirect subsidiaries to Brius Healthcare

Skilled Healthcare Group, Inc. today announced that five of its indirect subsidiaries that operate skilled nursing facilities in northern California have entered into an agreement to transfer their operations to Brius Healthcare, LLC and expects the transfer to be completed in April 2011 following the receipt of necessary regulatory approvals.

5 Mar 2011

Centric Health terminates acquisition of DNPI Group

Centric Health Corporation, Canada's leading diversified healthcare services company, today announced that in terms of previous announcements dated December 22, 2010 and January 12, 2011, it has terminated discussions for the acquisition of Dedicated National Pharmacies Inc., Methadrug Clinic Limited and Union Medical Pharmacy Inc. from the court-appointed receiver of the DNPI Group.

5 Mar 2011

Sequel Youth and Family Services acquires Camelot System of Care

Levine Leichtman Capital Partners, a Los Angeles-based private equity firm, announced today that Sequel Youth and Family Services, a portfolio company of Levine Leichtman Capital Partners IV, L.P., has completed the strategic acquisition of Camelot System of Care.

5 Mar 2011

Questcor Pharmaceuticals appoints BDO to audit its consolidated financial statements

Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.

5 Mar 2011

Summer Street Research announces recent closing of financing for IMUC

Summer Street Research Partners is pleased to announce the recent closing of a financing for ImmunoCellular Therapeutics, Ltd., a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers.

5 Mar 2011

Nephros completes its shareholders rights offering, related private placement financing

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced the completion of its rights offering and private placement that together will result in gross proceeds of approximately $3.2 million to Nephros.

5 Mar 2011

Lantheus commences solicitation with respect to 9.750% Senior Notes Due 2017

Lantheus Medical Imaging, Inc. today announced it commenced a consent solicitation with respect to a proposed amendment to the indenture governing the company's outstanding 9.750% Senior Notes Due 2017.

5 Mar 2011

Major providers of prison medical care set to merge

Valitas Health Services plans to acquire America Service Group for $250 million, merging two of the largest providers of correctional health care. Valitas, of St. Louis, is the parent company of Correctional Medical Services.

5 Mar 2011

Redpoint Bio fourth quarter revenues are $0.7 million for 2010

Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced financial and operational results for the quarter and year ended December 31, 2010.

5 Mar 2011

ThermoGenesis prices offering of 2,250,000 shares of common stock

ThermoGenesis Corp., a leading supplier of innovative products and services that process and store adult stem cells, said today that it has determined the pricing for an offering of shares and warrants.

4 Mar 2011

Prism Medical revenues in fiscal 2010 is $66.6 million

Prism Medical Ltd. today announced its results for the fiscal year ended November 30, 2010. Revenues in fiscal 2010 were $66.6 million compared to $65.7 million in fiscal 2009.

4 Mar 2011

Amgen acquires BioVex Group

Harris & Harris Group, Inc. notes that Amgen and BioVex Group, Inc., today announced the completion of the acquisition of BioVex Group, Inc.

4 Mar 2011

CBAI modifies authorized shares from pro-rata 500 to 250 million

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that the Company's management team and board of directors has modified the proposed one share for each 500 outstanding shares reverse stock split to one share for each 100 outstanding shares.

4 Mar 2011